These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4626523)

  • 21. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
    Tanira MO; Furman BL
    Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 24. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
    Haslbeck M; Brauch K; Hepp KD; Mehnert H
    Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
    Ohnota H; Kobayashi M; Koizumi T; Katsuno K; Sato F; Aizawa T
    Biochem Pharmacol; 1995 Jan; 49(2):165-71. PubMed ID: 7840793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
    Bickel M; Geisen K; Schleyerbach R
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G; Raptis S; Pfeiffer EF
    Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract]   [Full Text] [Related]  

  • 30. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 31. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological properties of 1,2-benzisothiazole compounds. Hypoglycemic activity of some benzisothiazolylacylamidoethylbenzensulfonylureas].
    Amoretti L; Agosti A; Catellani PL
    Boll Soc Ital Biol Sper; 1971 May; 47(10):299-302. PubMed ID: 4999859
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of gliquidone and glibenclamide following oral administration].
    Ziler T; Waldthaler A; Ermler R; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
    Schöffling K; Haupt E; Köberich W; Beyer J
    Klin Wochenschr; 1973 Jan; 51(2):68-77. PubMed ID: 4631325
    [No Abstract]   [Full Text] [Related]  

  • 35. [The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
    Vainer H; Verry M
    Thromb Res; 1974 Apr; 4(4):523-38. PubMed ID: 4215174
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiation of the insulinotropic and hypoglycemic action of gliquidone by succinic acid esters.
    García-Martínez JA; Villanueva-Peñacarrillo ML; Valverde I; Björkling F; Malaisse WJ
    Eur J Pharmacol; 1997 Apr; 325(1):65-8. PubMed ID: 9151940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.